Dr. Carla Torres-Zegarra is proud to announce that the "Pediatras En Línea" (PEL) Podcast went live on 5/26/21. Dr. Torres-Zegarra has already recorded nearly a dozen interviews with a variety of pediatric experts across Latin America and from Children’s Hospital Colorado, anticipating even broader success and engagement compared to Charting Pediatrics. The Podcast team is excited to be first to market a Podcast to provide timely pediatric medical education to Spanish-speaking providers and expand the reach and exposure of their pediatric expertise from Children’s Colorado that encompasses diverse voices.
The Melanoma Research Foundation is honored to award this year's Excellence in Prevention Award at the 2020 Denver Virtual Gala to Dr. Robert Dellavalle of Denver VA Medical Center. Dr. Dellavalle leads a prominent research laboratory focused on skin disease prevention and evidence-based dermatology that was the first to summarize global indoor UV tanning age restriction laws, measure compliance with tanning age restrictions, and to call for a tax on UV tanning. He is an amazing melanoma awareness advocate and MRF supporter. Please enjoy this "Meet the Honoree" session with Dr. Dellavalle to learn more about him, his active research in melanoma prevention and care and the Denver Virtual Gala!
The podcast Dermosphere recently reviewed the article "Spray sunscreen: characterizing application area density and implications for sun protection," co-authored by three of our faculty members: Drs. Robert Dellavalle, Cory Dunnick, and Jeremy Hugh. The article was recently published in the Journal of the American Academy of Dermatology.
You might have noticed some comically high-SPF sunscreens lining drugstore shelves. According to Theresa Pacheco of the University of Colorado School of Medicine, “SPF 15 is good. SPF 30 is better.” Anything higher, she says, doesn’t make much of a difference. An SPF 15 sunscreen will block about 93 percent of UVB rays, compared to 97 percent for SPF 30 and 98 percent for SPF 50.
The U.S. Department of Defense awarded $3.8 million to a consortium working to develop stem cell-based therapies for patients with inherited skin diseases such as epidermolysis bullosa (EB) and for wound care. “We are very excited to receive such a strong endorsement from the US Department of Defense,” said Ganna Bilousova, an associate professor of dermatology at the University of Colorado School of Medicine and member of the consortium. “It is extremely difficult to advance any type of novel therapies into the clinic without the benefit of compelling government interest and support.”
On Buddy Check9 Day, Robert Dellavalle from the University of Colorado School of Medicine and Neil Box talk about skin cancer. Dellavalle: “One of the things that we’re excited about is a camera that can show hidden UV damage.”